The securities regulator has just given the green light to eight companies, signaling a wave of new IPOs that could interest everyday investors.
Why the approvals matter
Even though market conditions are selective, SEBI’s nod shows that well‑established businesses with solid scale or niche strengths are comfortable moving toward a public listing, potentially as early as 2026.
Companies cleared for IPO
- Indira IVF – one of India’s largest fertility‑clinic chains. Plans to list in the next year, tapping growing demand for assisted reproductive services.
- Chartered Speed – Ahmedabad‑based passenger mobility firm. Targeting up to ₹855 crore (₹655 cr fresh equity + ₹200 cr offer‑for‑sale) from promoters.
- Glass Wall Systems India – façade solutions provider. Aiming to raise ₹60 crore via fresh shares while existing investors sell about 35.9% of the company.
- Shriram Food Industry Ltd. – part of the Greta Group, formerly Shriram Rice Udyog. Will issue up to 2.12 cr fresh shares and sell 52 lakh shares from promoters, totaling 2.64 cr shares.
- RKCPL – Gurgaon‑based civil construction and infrastructure developer. Seeking up to ₹1,250 crore (₹700 cr fresh issue + ₹550 cr promoter sell‑down) with a pre‑IPO raise of ₹140 cr.
- Tempsens Instruments (India) – medical device maker. Proposes a book‑built issue of ₹118 cr fresh equity plus an offer‑for‑sale of 1.79 cr shares.
- Jerai Fitness – will conduct a 100% offer‑for‑sale of 4,392,500 shares (₹10 face value). Proceeds go entirely to promoters.
- Rays of Belief – previously filed confidentially, now cleared to launch its public offer.
What investors should watch
- Sector exposure: The list covers healthcare, mobility, infrastructure, manufacturing and consumer goods, offering diversification.
- Fund‑raising size: Ranges from modest ₹60 cr raises to large ₹1,250 cr capital boosts, indicating varied growth ambitions.
- Promoter sell‑downs: Several companies include significant offer‑for‑sale components, which could affect post‑listing price stability.
- Timeline: While approvals are in place, actual listing dates may stretch into 2026, giving investors time to prepare.
Bottom line
These eight approvals suggest a cautious but steady pipeline of IPOs that could appeal to retail investors seeking exposure to growing Indian sectors. Keep an eye on the final prospectuses for pricing and allocation details.
Remember, this is perspective, not prediction. Do your own research before making any investment decisions.